Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Fentanyl	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[4] 46, 70, 215, 231 💬
2	Fentanyl (high dose)	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 215 💬
3	Fentanyl (low dose)	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 215 💬
4	Fentanyl (low dose) + dexmedetomidine	Dexmedetomidine	[4] D00320, D00514, D01205, D01399 💬	[4] ADRA2A, ADRA2B, ADRA2C, OPRM1 💬	[4] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway	[1] 215 💬
5	Fentanyl transdermal patch	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 46 💬
6	Multi-modal pain management [fentanyl]	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 70 💬
7	Standard analgesia use [fentanyl]	Fentanyl	[2] D00320, D01399 💬	[1] OPRM1 💬	[3] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction	[1] 70 💬
8	Transdermal fentanyl matrix, gabapentin	Fentanyl	[3] D00320, D00332, D01399 💬	[6] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬	[12] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle	[1] 70 💬